How Long Should Active Surveillance Last?April 22, 2024Genitourinary CancerPreventive CarePatient & Survivor Care
Why Lung Cancer Screening Is Not for EveryoneApril 19, 2024Preventive CareLung CancerPatient & Survivor Care
Adding ACEI to Chemotherapy Does Not Prevent CardiotoxicityApril 19, 2024Patient & Survivor CareBreast CancerLymphoma & Plasma Cell DisordersPreventive CareMixed Topics
What’s Driving the Higher Breast Cancer Death Rate in Black Women?April 18, 2024Breast CancerDiversity in MedicinePreventive CareMetastatic Breast CancerPractice ManagementPatient & Survivor Care
Microbial Signature of KRAS-Mutated Colorectal Cancer IdentifiedApril 18, 2024Gastrointestinal CancerGastroenterologyPatient & Survivor Care
Certain Women May Face Higher Risk for Second Breast CancerApril 17, 2024Breast CancerMetastatic Breast CancerPatient & Survivor Care
Most Targeted Cancer Drugs Lack Substantial Clinical BenefitApril 17, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Blood Test Shows Promise for Improving CRC ScreeningApril 16, 2024Gastrointestinal CancerGastroenterologyPreventive CarePatient & Survivor Care
Is Axillary Surgery in Early Breast Cancer on Its Way Out?April 16, 2024Breast CancerPatient & Survivor Care
How New ICI Combos Change Bladder Cancer ManagementApril 15, 2024Genitourinary CancerImmunotherapyImmuno-oncologyPatient & Survivor Care
How Medicare Reimbursement Trends Could Affect Breast SurgeriesApril 15, 2024Practice ManagementBreast CancerMetastatic Breast CancerPatient & Survivor Care
No Routine Cancer Screening Option? New MCED Tests May HelpApril 15, 2024Preventive CarePractice ManagementPatient & Survivor CareRenal Cell CarcinomaSarcoma & GISTNonmelanoma Skin CancerNeuro-oncology
Ovarian Cancer: Another Promising Target for Liquid BiopsyApril 15, 2024Gynecologic CancerPreventive CarePatient & Survivor Care
Oncologists Voice Ethical Concerns Over AI in Cancer CareApril 12, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
GLP-1 Receptor Agonists Don’t Raise Thyroid Cancer RiskApril 12, 2024Head & Neck/Thyroid CancersPatient & Survivor Care
